92 related articles for article (PubMed ID: 7879049)
1. Rapamycin (Sirolimus) inhibits vascular smooth muscle DNA synthesis in vitro and suppresses narrowing in arterial allografts and in balloon-injured carotid arteries: evidence that rapamycin antagonizes growth factor action on immune and nonimmune cells.
Morris RE; Cao W; Huang X; Gregory CR; Billingham ME; Rowan R; Shorthouse RA
Transplant Proc; 1995 Feb; 27(1):430-1. PubMed ID: 7879049
[No Abstract] [Full Text] [Related]
2. Treatment with rapamycin blocks arterial intimal thickening following mechanical and alloimmune injury.
Gregory CR; Huie P; Shorthouse R; Wang J; Rowan R; Billingham ME; Morris RE
Transplant Proc; 1993 Feb; 25(1 Pt 1):120-1. PubMed ID: 8438246
[No Abstract] [Full Text] [Related]
3. Effects of treatment with cyclosporine, FK 506, rapamycin, mycophenolic acid, or deoxyspergualin on vascular muscle proliferation in vitro and in vivo.
Gregory CR; Pratt RE; Huie P; Shorthouse R; Dzau VJ; Billingham ME; Morris RE
Transplant Proc; 1993 Feb; 25(1 Pt 1):770-1. PubMed ID: 7679842
[No Abstract] [Full Text] [Related]
4. Effects of rapamycin on growth factor-stimulated vascular smooth muscle cell DNA synthesis. Inhibition of basic fibroblast growth factor and platelet-derived growth factor action and antagonism of rapamycin by FK506.
Cao W; Mohacsi P; Shorthouse R; Pratt R; Morris RE
Transplantation; 1995 Feb; 59(3):390-5. PubMed ID: 7532879
[TBL] [Abstract][Full Text] [Related]
5. Effect of cyclosporine, mycophenolic acid, and rapamycin on the proliferation of rat aortic vascular smooth muscle cells: in vitro study.
Moon JI; Kim YS; Kim MS; Kim EH; Kim HJ; Kim SI; Park K
Transplant Proc; 2000 Nov; 32(7):2026-7. PubMed ID: 11120050
[No Abstract] [Full Text] [Related]
6. Differential effects of modern immunosuppressive agents on the development of intimal hyperplasia.
Waller JR; Brook NR; Bicknell GR; Nicholson ML
Transpl Int; 2004 Jan; 17(1):9-14. PubMed ID: 14551676
[TBL] [Abstract][Full Text] [Related]
7. Endocardial mononuclear cell infiltrates (Quilty effect) in heterotopic cardiac allografts in rapamycin-treated rats.
Mohacsi PJ; Joshi A; Wang J; Morris RE; Billingham ME
Transplant Proc; 1994 Dec; 26(6):3255-9. PubMed ID: 7998133
[No Abstract] [Full Text] [Related]
8. Blockade of vascular smooth muscle cell proliferation and intimal thickening after balloon injury by the sulfated oligosaccharide PI-88: phosphomannopentaose sulfate directly binds FGF-2, blocks cellular signaling, and inhibits proliferation.
Francis DJ; Parish CR; McGarry M; Santiago FS; Lowe HC; Brown KJ; Bingley JA; Hayward IP; Cowden WB; Campbell JH; Campbell GR; Chesterman CN; Khachigian LM
Circ Res; 2003 May; 92(8):e70-7. PubMed ID: 12690039
[TBL] [Abstract][Full Text] [Related]
9. In vivo use of rapamycin suppresses neither IL-2 production nor IL-2 receptor expression in rat transplant model.
Hamashima T; Yoshimura N; Ohsaka Y; Oka T; Stepkowski SM; Kahan BD
Transplant Proc; 1993 Feb; 25(1 Pt 1):723-4. PubMed ID: 8438457
[No Abstract] [Full Text] [Related]
10. Rapamycin inhibits spontaneous and fibroblast growth factor beta-stimulated proliferation of endothelial cells and fibroblasts.
Akselband Y; Harding MW; Nelson PA
Transplant Proc; 1991 Dec; 23(6):2833-6. PubMed ID: 1721292
[No Abstract] [Full Text] [Related]
11. TAS-301, an inhibitor of smooth muscle cell migration and proliferation, inhibits intimal thickening after balloon injury to rat carotid arteries.
Muranaka Y; Yamasaki Y; Nozawa Y; Terakawa H; Tanahashi Y; Oda N; Satoh A; Asao T; Miyake H; Matsuura N
J Pharmacol Exp Ther; 1998 Jun; 285(3):1280-6. PubMed ID: 9618434
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of rapamycin, cyclosporine A, and FK506 on human coronary artery smooth muscle cell proliferation and signalling.
Hafizi S; Mordi VN; Andersson KM; Chester AH; Yacoub MH
Vascul Pharmacol; 2004; 41(4-5):167-76. PubMed ID: 15607500
[TBL] [Abstract][Full Text] [Related]
13. Effect of immunosuppressive drugs (CsA, FK 506, rapamycin) on the kidney microsomal cytochrome P-450 system in the rat.
Yoshimura R; Yoshimura N; Ohmachi T; Nakatani T; Ohyama A; Miyao Y; Yamamoto K; Kishimoto T
Transplant Proc; 1994 Oct; 26(5):2890. PubMed ID: 7524223
[No Abstract] [Full Text] [Related]
14. Suppression of neointimal thickening by a newly developed HMG-CoA reductase inhibitor, BAYw6228, and its inhibitory effect on vascular smooth muscle cell growth.
Igarashi M; Takeda Y; Mori S; Ishibashi N; Komatsu E; Takahashi K; Fuse T; Yamamura M; Kubo K; Sugiyama Y; Saito Y
Br J Pharmacol; 1997 Mar; 120(6):1172-8. PubMed ID: 9134232
[TBL] [Abstract][Full Text] [Related]
15. Rapamycin treatment prevents and/or erases sensitization and abrogates accelerated rejection of vascularized organ allografts.
Schmidbauer G; Hancock WW; Wasowska BA; Sablinski T; Kupiec-Weglinski JW
Transplant Proc; 1993 Feb; 25(1 Pt 1):712-3. PubMed ID: 8438450
[No Abstract] [Full Text] [Related]
16. Beneficial effects of cyclosporine and rapamycin in small bowel ischemic injury.
Puglisi RN; Strande L; Santos M; Schulte G; Hewitt CW; Whalen TV
J Surg Res; 1996 Oct; 65(2):115-8. PubMed ID: 8903456
[TBL] [Abstract][Full Text] [Related]
17. Different inhibitory effects of immunosuppressive drugs on human and rat aortic smooth muscle and endothelial cell proliferation stimulated by platelet-derived growth factor or endothelial cell growth factor.
Mohacsi PJ; Tüller D; Hulliger B; Wijngaard PL
J Heart Lung Transplant; 1997 May; 16(5):484-92. PubMed ID: 9171265
[TBL] [Abstract][Full Text] [Related]
18. Effects of immunosuppressive therapy on the rat aortic allograft model.
Steele DM; Hullett DA; Bechstein WO; Kowalski J; Smith LS; Kennedy E; Allison AC; Sollinger HW
Transplant Proc; 1993 Feb; 25(1 Pt 1):754-5. PubMed ID: 8438469
[No Abstract] [Full Text] [Related]
19. The effect of combined rapamycin/cyclosporine on the changes in pro-fibrotic gene expression that occur during the development of allograft vasculopathy in rats, compared with cyclosporine or rapamycin in isolation.
Murphy GJ; Bicknell GR; Nicholson ML
Transpl Int; 2003 May; 16(5):347-53. PubMed ID: 12759727
[TBL] [Abstract][Full Text] [Related]
20. Effect of immunosuppression on chronic rejection in the rat aortic allograft model.
Belitsky P; Gulanikar A; He G; Gupta R
Transplant Proc; 1993 Feb; 25(1 Pt 2):935. PubMed ID: 8442272
[No Abstract] [Full Text] [Related]
[Next] [New Search]
